Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9Z3Z

Cryo-EM structure of human nonmuscle myosin-2B, Class 2

Summary for 9Z3Z
Entry DOI10.2210/pdb9z3z/pdb
Related9Z3W
EMDB information73796
DescriptorMyosin-10, Myosin light polypeptide 6, Myosin regulatory light chain 12B, ... (6 entities in total)
Functional Keywordsmyosin, atpase, motor protein
Biological sourceHomo sapiens (human)
More
Total number of polymer chains6
Total formula weight533058.04
Authors
Heissler, S.M.,Chinthalapudi, K. (deposition date: 2025-11-07, release date: 2026-07-08)
Primary citationHeissler, S.M.,Grandinetti, G.,Sellers, J.R.,Chinthalapudi, K.
Structural basis of nonmuscle myosin-2 autoinhibition mechanisms.
Nat Commun, 2026
Cited by
PubMed Abstract: Nonmuscle myosin-2 (NM2) is a fundamental actin-based mechanochemical ATPase that regulates cellular architecture, migration, adhesion, and force generation across diverse biological contexts. NM2 function is tightly regulated by a structural transition between an autoinhibited monomeric (10S) conformation in which ATPase activity, actin binding, and filament assembly are coordinately suppressed and an enzymatically active, filamentous conformation. The autoinhibited conformation is critical for the spatial and temporal control of contractility in nonmuscle cells, yet structural insights into the 10S conformation remain largely elusive. Here, we report a ~53-nm elongated full-length structure of NM2B in the 10S conformation and four distinct cryo-EM structures representing the conformational landscape within the human NM2B 10S state. These structures reveal a tri-segmented tail fold that sequesters interfaces essential for actin binding and filament assembly. The asymmetric arrangement of myosin heavy and light chains provides a mechanistic foundation for understanding how regulatory post-translational modifications and disease-associated mutations shift NM2 conformational equilibria and may enable the development of structure-based interventions for cytoskeletal diseases including hearing loss, neurodegeneration, and cancer.
PubMed: 42323327
DOI: 10.1038/s41467-026-74674-w
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (5.24 Å)
Structure validation

256158

PDB entries from 2026-07-08

PDB statisticsPDBj update infoContact PDBjnumon